20
Centaur Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLORDIAZEPOXIDE USP, with a corresponding US DMF Number 25335.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2016, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II